000			02327 a2200673 4500
005			20250516162053.0
264		0	_c20131104
008			201311s 0 0 eng d
022			_a1474-5488
024	7		_a10.1016/S1470-2045(13)70310-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aGarassino, Marina Chiara
245	0	0	_aErlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial. _h[electronic resource]
260			_bThe Lancet. Oncology _cSep 2013
300			_a981-8 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aCarcinoma, Non-Small-Cell Lung _xdrug therapy
650	0	4	_aDisease-Free Survival
650	0	4	_aDocetaxel
650	0	4	_aErbB Receptors _xantagonists & inhibitors
650	0	4	_aErlotinib Hydrochloride
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLung Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMutation
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aProto-Oncogene Proteins _xgenetics
650	0	4	_aProto-Oncogene Proteins p21(ras)
650	0	4	_aQuinazolines _xtherapeutic use
650	0	4	_aTaxoids _xtherapeutic use
650	0	4	_aras Proteins _xgenetics
700	1		_aMartelli, Olga
700	1		_aBroggini, Massimo
700	1		_aFarina, Gabriella
700	1		_aVeronese, Silvio
700	1		_aRulli, Eliana
700	1		_aBianchi, Filippo
700	1		_aBettini, Anna
700	1		_aLongo, Flavia
700	1		_aMoscetti, Luca
700	1		_aTomirotti, Maurizio
700	1		_aMarabese, Mirko
700	1		_aGanzinelli, Monica
700	1		_aLauricella, Calogero
700	1		_aLabianca, Roberto
700	1		_aFloriani, Irene
700	1		_aGiaccone, Giuseppe
700	1		_aTorri, Valter
700	1		_aScanni, Alberto
700	1		_aMarsoni, Silvia
773	0		_tThe Lancet. Oncology _gvol. 14 _gno. 10 _gp. 981-8
856	4	0	_uhttps://doi.org/10.1016/S1470-2045(13)70310-3 _zAvailable from publisher's website
999			_c22945317 _d22945317